BETHANY VOLKART: Open Payments
NPI 1790237949 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 19 payments from 10 companies in 2025. Trend: 2023 $532 · 2024 $442 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $147 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| ABBVIE INC. | 3 | $61 |
| Janssen Biotech, Inc. | 2 | $52 |
| Almirall LLC | 2 | $32 |
| Lilly USA, LLC | 2 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $9 |
Products named: Bimzelx, TREMFYA, RINVOQ, COSENTYX, Seysara, TALTZ, Rhapsido, Winlevi.
Industry payments across MO — which companies pay providers there.
